Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

J Cancer 2021; 12(7):2030-2040. doi:10.7150/jca.51565 This issue Cite

Research Paper

Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer

Zhiyu Ji, Aoning Mi, Mengmeng Li, Quanying Li, Changjiang Qin✉

Department of General Surgery, Huaihe Hospital of Henan University, Kaifeng, China.

✉ Corresponding author: Changjiang Qin, Department of General Surgery, Huaihe Hospital of Henan University, No. 8 of Baobei Road, Kaifeng, 475000, China. E-mail: qincjhenu.edu.cn.

Citation:
Ji Z, Mi A, Li M, Li Q, Qin C. Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer. J Cancer 2021; 12(7):2030-2040. doi:10.7150/jca.51565. https://www.jcancer.org/v12p2030.htm
Other styles

File import instruction

Abstract

Graphic abstract

Purpose: The aim of the present study was to reveal the clinicopathological significance and prognostic role of kinesin family member 23 (KIF23) in colorectal cancer (CRC) and characterize its biological function and the underlying mechanisms.

Methods: Bioinformatics analysis, immunohistochemistry, Western blot and qRT-PCR were utilized to investigate the expression of KIF23 in CRC tissues. The CCK-8 assay, wound healing assay and Matrigel assay were used to detect cell proliferation, migration and invasion in vitro. Western blot, immunofluorescence staining and cell function experiment were performed to explore the underlying mechanism.

Results: The overexpression of KIF23 was associated with T stage, N stage, M stage and TNM stage, and CRC patients with high KIF23 expression had a worse prognosis. KIF23 knockdown inhibits CRC cells proliferation, migration and invasion in vitro. The mechanism study determined that KIF23 activates the Wnt/β-catenin signaling pathway by promoting the nuclear translocation of β-catenin to regulate the malignant behavior of CRC cells.

Conclusion: These results suggest that KIF23 may act as a putative oncogene and a potential therapeutic target in CRC.

Keywords: KIF23, Colorectal cancer, Proliferation, Migration, Wnt/β-catenin

Citation styles

APA
Ji, Z., Mi, A., Li, M., Li, Q., Qin, C. (2021). Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer. Journal of Cancer, 12(7), 2030-2040. https://doi.org/10.7150/jca.51565.

ACS
Ji, Z.; Mi, A.; Li, M.; Li, Q.; Qin, C. Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer. J. Cancer 2021, 12 (7), 2030-2040. DOI: 10.7150/jca.51565.

NLM
Ji Z, Mi A, Li M, Li Q, Qin C. Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer. J Cancer 2021; 12(7):2030-2040. doi:10.7150/jca.51565. https://www.jcancer.org/v12p2030.htm

CSE
Ji Z, Mi A, Li M, Li Q, Qin C. 2021. Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer. J Cancer. 12(7):2030-2040.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use